TY - JOUR
T1 - Left atrial function in heart failure with preserved ejection fraction
T2 - a systematic review and meta-analysis
AU - Khan, Muhammad Shahzeb
AU - Memon, Muhammad Mustafa
AU - Murad, Mohammad H.
AU - Vaduganathan, Muthiah
AU - Greene, Stephen J.
AU - Hall, Michael
AU - Triposkiadis, Filippos
AU - Lam, Carolyn S.P.
AU - Shah, Amil M.
AU - Butler, Javed
AU - Shah, Sanjiv J.
N1 - Funding Information:
M.V. is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (NIH/NCATS Award UL 1TR002541) and serves on advisory boards for Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, and Relypsa. S.J.G. is supported by a Heart Failure Society of America/Emergency Medicine Foundation Acute Heart Failure Young Investigator Award funded by Novartis, and has received research support from Amgen, Bristol‐Myers Squibb, and Novartis; and serves on an advisory board for Amgen. J.B. has received research support from the NIH and European Union; and has been a consultant for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol‐Myers Squibb, CVRx, Janssen, Luitpold Pharmaceuticals, Medtronic, Merck, Novartis, Relypsa, Vifor Pharma, and ZS Pharma. S.J.S. is the principal investigator of the REDUCE LAP‐HF I and II trials of the Corvia InterAtrial Shunt Device, and has received research grants from Corvia. The other authors have no conflicts of interest. Conflict of interest:
Publisher Copyright:
© 2020 European Society of Cardiology
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Aims: Left atrial (LA) mechanical function may play a significant role in the development and progression of heart failure with preserved ejection fraction (HFpEF). We performed a systematic review and meta-analysis to evaluate association of impaired LA function with outcomes in HFpEF. Methods and results: Multiple databases were searched for original studies measuring different phases of LA function in HFpEF patients. Comparative LA function between HFpEF patients and healthy controls was assessed by pooling weighted mean differences (WMD). Adjusted hazard ratios (HRs) with 95% confidence intervals were pooled to evaluate the prognostic utility of LA function. Twenty-two studies (2 trials, 20 observational) comprising 1974 HFpEF patients and 751 healthy controls were included. HFpEF patients had decreased LA reservoir [WMD = −12.21% (−15.47, −8.95); P < 0.001], LA conduit [WMD = −5.68% (−8.56, −2.79); P < 0.001], and pump [WMD = −11.07% (−14.81, −7.34); P < 0.001] emptying fractions compared with controls. LA reservoir [WMD = −13.38% (−16.07, −10.68); P < 0.001], conduit [WMD = −4.09% (−6.77, −1.42); P = 0.003], and pump [WMD = −3.53% (−4.47, −2.59); P < 0.001] strains were also significantly lower in HFpEF patients. Decreased LA reservoir strain [HR 1.24 (1.02, 1.50); P = 0.03] was significantly associated with risk of composite all-cause mortality or heart failure hospitalization. Conclusions: Impaired LA function appears to have diagnostic and prognostic value in HFpEF, but whether indices of LA function truly refine discrimination for diagnosis or prognosis remains to be fully determined. Larger studies are needed to better evaluate associations between LA function and clinical outcomes and the role of LA function as a target for novel HFpEF therapies.
AB - Aims: Left atrial (LA) mechanical function may play a significant role in the development and progression of heart failure with preserved ejection fraction (HFpEF). We performed a systematic review and meta-analysis to evaluate association of impaired LA function with outcomes in HFpEF. Methods and results: Multiple databases were searched for original studies measuring different phases of LA function in HFpEF patients. Comparative LA function between HFpEF patients and healthy controls was assessed by pooling weighted mean differences (WMD). Adjusted hazard ratios (HRs) with 95% confidence intervals were pooled to evaluate the prognostic utility of LA function. Twenty-two studies (2 trials, 20 observational) comprising 1974 HFpEF patients and 751 healthy controls were included. HFpEF patients had decreased LA reservoir [WMD = −12.21% (−15.47, −8.95); P < 0.001], LA conduit [WMD = −5.68% (−8.56, −2.79); P < 0.001], and pump [WMD = −11.07% (−14.81, −7.34); P < 0.001] emptying fractions compared with controls. LA reservoir [WMD = −13.38% (−16.07, −10.68); P < 0.001], conduit [WMD = −4.09% (−6.77, −1.42); P = 0.003], and pump [WMD = −3.53% (−4.47, −2.59); P < 0.001] strains were also significantly lower in HFpEF patients. Decreased LA reservoir strain [HR 1.24 (1.02, 1.50); P = 0.03] was significantly associated with risk of composite all-cause mortality or heart failure hospitalization. Conclusions: Impaired LA function appears to have diagnostic and prognostic value in HFpEF, but whether indices of LA function truly refine discrimination for diagnosis or prognosis remains to be fully determined. Larger studies are needed to better evaluate associations between LA function and clinical outcomes and the role of LA function as a target for novel HFpEF therapies.
KW - Heart failure with preserved ejection fraction
KW - Left atrium
KW - Meta-analysis
KW - Remodelling
UR - http://www.scopus.com/inward/record.url?scp=85077867361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077867361&partnerID=8YFLogxK
U2 - 10.1002/ejhf.1643
DO - 10.1002/ejhf.1643
M3 - Article
C2 - 31919960
AN - SCOPUS:85077867361
SN - 1388-9842
VL - 22
SP - 472
EP - 485
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 3
ER -